Adam Feuerstein
Adam Feuerstein is an American blogger and columnist who covers the biotechnology industry. He studied political science at Emory University. Early in his career, he worked at the San Francisco Business Times and the Atlanta Business Chronicle, and wrote about business software for Upside.com. He joined TheStreet.com in 2001, spent a year as a hedge fund research analyst in 2005–2006, then returned to TheStreet until resigning in May 2017. In June 2017, he became the national biotechnology columnist for STAT. Feuerstein is known for his outspoken reporting and active Twitter presence, where he shares strong opinions on biotech stocks and the FDA.
This page was last edited on 2 February 2026, at 23:28 (CET).